Märkte & Kurse

Übersicht
Suchanfrage
Produktinformation
 

Auf dieser Seite finden Sie alle Nachrichten zeitlich geordnet und zu unterschiedlichen Themen der letzten drei Tage aufgelistet. Wählen Sie aus der untenstehenden Tabelle die für Sie interessante Nachricht aus. Zusätzlich können Sie auch unsere Nachrichtensuche nutzen, um damit noch detaillierter nach bestimmten und weiter zurückliegenden Nachrichten zu suchen.

 

Ausgewählte Nachricht
23.05.2024 07:05

GNW-Adhoc: Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders

    ^Allschwil, Switzerland - May 23, 2024
Idorsia Ltd (SIX: IDIA) today issued the invitation to the upcoming Annual
General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The
meeting to approve the Annual Report of the year ending December 31, 2023, will
be held on Thursday, June 13, 2024, at 09.00 CEST at the Congress Center, Messe
Basel, Switzerland.
Notes to Shareholders
The invitation was published in the Swiss Official Gazette of Commerce
(Schweizerisches Handelsamtsblatt) today and will be distributed to Shareholders
by post. It is also available, together with the company's Annual Report,
consisting of the Business Report, Governance Report, Compensation Report,
Financial Report, and for the first time, Sustainability Report, at
www.idorsia.com/agm (http://www.idorsia.com/agm).
In order to attend and vote at the AGM, shareholders must be registered in the
company's shareholder register by June 4, 2024, 17:00 CEST, at the latest.
Notes to the editor
Agenda for the AGM 2024
1.   Annual reporting 2023
1.1      Vote on Annual Report 2023, Consolidated Financial Statements 2023,
and Statutory Financial Statements 2023
1.2      Consultative vote on the Compensation Report 2023
1.3      Consultative vote on the Sustainability Report 2023
2.   Appropriation of available earnings
3.   Discharge of the Board of Directors and of the Executive Committee
4.   Amendments to the Articles of Association regarding share capital
4.1      Increase of conditional share capital
4.2      Deletion of Article 3C
5.   Board elections
5.1      (Re-)election of members of the Board of Directors
5.2      Election of the Chair of the Board of Directors
5.3      Re-election of members of the Nominating, Governance & Compensation
Committee
6.   Vote on Board compensation and Executive Committee compensation
6.1      Approval of Board compensation (Non-Executive Directors) for the
2024-2025 term of office
6.2      Approval of Executive Committee compensation for 2025
7.   Re-election of the Independent Proxy
8.   Election of the statutory auditors
About Idorsia
Idorsia Ltd is reaching out for more - We have more ideas, we see more
opportunities and we want to help more patients. In order to achieve this, we
will develop Idorsia into a leading biopharmaceutical company, with a strong
scientific core.
Headquartered near Basel, Switzerland - a European biotech-hub - Idorsia is
specialized in the discovery, development and commercialization of small
molecules to transform the horizon of therapeutic options. Idorsia has a 25-year
heritage of drug discovery, a broad portfolio of innovative drugs in the
pipeline, an experienced team of professionals covering all disciplines from
bench to bedside, and commercial operations in Europe and North America - the
ideal constellation for bringing innovative medicines to patients.
Idorsia was listed on the SIX Swiss Exchange (ticker symbol: IDIA) in June 2017
and has over 750 highly qualified specialists dedicated to realizing our
ambitious targets.
For further information, please contact
Andrew C. Weiss
Senior Vice President, Head of Investor Relations & Corporate Communications
Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil
+41 58 844 10 10
investor.relations@idorsia.com (mailto:investor.relations@idorsia.com)
media.relations@idorsia.com (mailto:media.relations@idorsia.com)
www.idorsia.com (http://www.idorsia.com)
The above information contains certain "forward-looking statements", relating to
the company's business, which can be identified by the use of forward-looking
terminology such as "estimates", "believes", "expects", "may", "are expected
to", "will", "will continue", "should", "would be", "seeks", "pending" or
"anticipates" or similar expressions, or by discussions of strategy, plans or
intentions. Such statements include descriptions of the company's investment and
research and development programs and anticipated expenditures in connection
therewith, descriptions of new products expected to be introduced by the company
and anticipated customer demand for such products and products in the company's
existing portfolio. Such statements reflect the current views of the company
with respect to future events and are subject to certain risks, uncertainties
and assumptions. Many factors could cause the actual results, performance or
achievements of the company to be materially different from any future results,
performances or achievements that may be expressed or implied by such forward-
looking statements. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, actual results
may vary materially from those described herein as anticipated, believed,
estimated or expected.
°


Weitere Nachrichten
Name Kurs Währung Datum Zeit Handelsplatz
IDORSIA AG NAMENS-AK... 2,360 USD 10.06.24 20:46 FINRA ot...
 
Weitere Nachrichten der letzten drei Tage 
Seiten:   14 15 16 17 18    Berechnete Anzahl Nachrichten: 752     
Datum Zeit Nachrichtenüberschrift
25.06.2024 08:19 ANALYSE-FLASH: JPMorgan setzt SAP auf 'Positive Catalyst Wat...
25.06.2024 08:15 Chinas Raumkapsel mit Mondgestein zurück auf der Erde
25.06.2024 08:15 Aktien Frankfurt Ausblick: Airbus belastet Dax mit Gewinnwar...
25.06.2024 08:12 Barclays senkt Ziel für Airbus auf 176 Euro - 'Overweight'
25.06.2024 08:10 IRW-News: Fast Finance 24 Holding AG: bereitet die US-Tochte...
25.06.2024 08:10 Ölpreise bauen Vortagsgewinne leicht aus
25.06.2024 08:02 Evotec erhält weiteren Auftrag vom US-Verteidigungsminister...
25.06.2024 08:01 Original-Research: PSI Software SE (von GSC Research GmbH): ...
25.06.2024 07:57 EQS-Stimmrechte: Commerzbank Aktiengesellschaft (deutsch)
25.06.2024 07:50 ANALYSE-FLASH: UBS hebt Ziel für Deutsche Börse auf 220 Eu...
25.06.2024 07:50 ANALYSE-FLASH: RBC senkt Ziel für Airbus auf 180 Euro - 'Ou...
25.06.2024 07:44 JPMorgan belässt Siemens Healthineers auf 'Overweight'
25.06.2024 07:40 IRW-News: MiMedia Holdings Inc.: MiMedia meldet Unterzeichnu...
25.06.2024 07:33 Goldman belässt Microsoft auf 'Buy' - Ziel 515 Dollar
25.06.2024 07:33 Devisen: Euro kostet weiter mehr als 1,07 US-Dollar
25.06.2024 07:32 dpa-AFX Börsentag auf einen Blick: Dax bleibt auf Richtungs...
25.06.2024 07:30 EQS-News: Just - Evotec Biologics vom US-amerikanischen Vert...
25.06.2024 07:29 JPMorgan belässt LVMH auf 'Neutral' - Ziel 790 Euro
25.06.2024 07:27 KORREKTUR/ROUNDUP/Baerbock in Nahost: Hisbollah neben Gazast...
25.06.2024 07:22 JPMorgan senkt Ziel für Airbus auf 172 Euro - 'Overweight'
Suche
Durchsuchen Sie unser Nachrichtenangebot unter Angabe eines von Ihnen gesuchten Begriffs.




 
Weitere Nachrichten
Lesen Sie auch weitere interessante Nachrichten u.a. zu den Themen Aktien im Fokus, Hintergrundberichte, Börsentag auf einem Blick, Wochenausblick oder adhoc-Mitteilungen.
 
Börsenkalender
26.06.2024

CRESCENDO CORP
Geschäftsbericht

STRAT AERO PLC
Geschäftsbericht

MONEGA KAPITALANLAGEGESELLSCHAFT MBH
Geschäftsbericht

ZEPHYR ENERGY
Geschäftsbericht

Übersicht
 

FactSet
Implemented and powered by FactSet. Bereitstellung der Kurs- und Marktinformationen erfolgt durch FactSet.
Bitte beachten Sie die Risikohinweise und Quellenangaben der TARGOBANK, die für diese Seite gelten.
 

 

Produkte und Services